Tesamorelin

About this material

Tesamorelin is a 44-amino acid synthetic peptide analog manufactured using precision Solid-Phase Peptide Synthesis (SPPS) under controlled production parameters designed to achieve high sequence fidelity, molecular consistency, and reproducible batch quality. Structurally derived from the endogenous human growth hormone-releasing hormone (GHRH) peptide sequence, Tesamorelin incorporates targeted amino acid modifications that produce a chemically defined molecular architecture while maintaining analytical consistency throughout the manufacturing process. Following synthesis, the peptide is purified using High-Performance Liquid Chromatography (HPLC) before controlled lyophilization.

Each production batch undergoes analytical characterization to verify molecular identity, chromatographic purity, peptide content, and overall physicochemical quality prior to release. Standardized synthesis and purification controls support consistent batch-to-batch reproducibility and product quality. Every production lot is accompanied by a batch-specific Certificate of Analysis (COA) documenting analytical verification, quality control review, and complete manufacturing traceability, providing a thoroughly characterized research material for scientific and analytical laboratory investigations.